• Aucun résultat trouvé

Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.

N/A
N/A
Protected

Academic year: 2021

Partager "Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient."

Copied!
6
0
0

Texte intégral

(1)

HAL Id: inserm-00133169

https://www.hal.inserm.fr/inserm-00133169

Submitted on 27 Feb 2007

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of sci-entific research documents, whether they are

pub-L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non,

Selection of a multiple drug-resistant hepatitis B virus

strain in a liver-transplanted patient.

Stéphanie Villet, Christian Pichoud, Jean-Pierre Villeneuve, Christian Trépo,

Fabien Zoulim

To cite this version:

Stéphanie Villet, Christian Pichoud, Jean-Pierre Villeneuve, Christian Trépo, Fabien Zoulim. Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.. Gastroenterology, WB Saunders, 2006, 131 (4), pp.1253-61. �10.1053/j.gastro.2006.08.013�. �inserm-00133169�

(2)

Genotype E ADV HBIg TENO LAM 1 2 3 4 5 6 7 9 to 16 Serum samples: 8 HBsAg: + + + + + - - + + 1,00E+02 1,00E+03 1,00E+04 1,00E+05 1,00E+06 1,00E+07 1,00E+08 0 20 40 60 80 100 120 months of treatment HBV DNA (IU/ml) Liver transplantation

(3)

0 10 20 30 40 50 60 70 80 90 100 0 10 20 30 40 50 60 70 80 90 100 C107stop P120S percentage of the mutations months of treatment Liver transplantation 1 2 3 4 5 6 7 8 to 13 Serum samples

(4)

lamivudine

treatment

(

months

)

0 10 20 30 40 50 60 70 80 90 100 0 24

% of variants in the viral quasi-species

Viral rebound

wt (S:66) wt (S:14) L180M+M204V (S:0) M204I (S:50) L180M+A181V (S:12) L180M+T184I+M204V (S:25) 1 18 L180M+A200V+M204V (S:25) L180M+A200V+M204V (S:0) 12 M204V (S:0)

(5)

0 10 20 30 40 50 60 70 80 90 100 1 L180M+M204I (S:100) wt (S:14) V173L+L180M+A181V+M204V (S:100) M204I (S:100) V173L+L180M+A181V (S:83) V173L+L180M+A181V+M204V+N236T (S:100) V173L+L180M+A181V+N236T (S:100) V173L+L180M+A181V+N236T (S:100) V173L+L180M+A181V+N236T (S:100) V173L+L180M+A181V+M204V+N236T (S:100) V173L+L180M+A181V+M204V (S:100) V173L+L180M+A181V+M204V (S:100) V173L+L180M+A181V+M204V (S:100) V173L+L180M+A181V+M204V (S:100) L180M+M204I (S:100) N236T (S:0) V173L+L180M+A181V+M204I (S:100) I169V+L180M+T184I+M204V (S:0)

Lamivudine

+

adefovir

treatment

(

months

)

1 8 24 34 38 40 42 to 50

Viral rebound

0 16 26 30 32 34 to 42

Time post-transplantation (

months

)

V173L+L180M+A181V+N236T (S:100)

(6)

1 wt V173L+L180M+A181V V173L+L180M+A181V+M204VV173L+L180M+A181V+N236T V173L+L180M+A181V+M204V+N236T

A

B

0 20 40 60 80 100 120 140 11 wt L180M+M204V L180M+T184I+M204V

L180M+A200V+M204V

M204I

L180M+A181V 0 20 40 60 80 100 120 1

Références

Documents relatifs

Interestingly, the 113 overexpression of human NTCP in permissive hepatoma cells such as Huh7 and HepG2 114 cells that lack endogenous expression of NTCP, conferred

Dans la forêt profonde, les renards et les blaireaux creusent leur terrier?. Qui joue de la flûte dans

Crystal structure analysis of the apo and the holo form of BC2L-C-nt demonstrated the presence of a druggable region (site X) in the vicinity of the fucoside binding site.

quently, we propose the Step-up Test Procedure to select the qualified alternative pro- cesses from I processes under non-linear profile data, I > 1.. The proposed method con-

Lorsqu’un écrit scientifique issu d’une activité de recherche financée au moins pour moitié par des dotations de l’État, des collectivités territoriales ou des

More generally speaking, if we have a singular curve C, the set of valuation rings of its rational function field is in bijection with the set of points of a non-singular model C ′

The very high rate of rpoB S531L mutation may correlate with some specific features of the national TB control pro- gram (quality of the drug used) or is hypothetically linked

In cases of resistance to rifampin and isoniazid, testing was performed by using the same liquid culture system with critical concentrations for amikacin (1.0 mg/L), kanamycin